
A large team of researchers from Denali Therapeutics has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical trial. Learn more at medicalxpress.com/news/2022-06-c….

English
CureClick
1.8K posts

@CureClickTeam
CureClick is a community-powered platform that revolutionizes the way companies find volunteers for their #ClinicalTrials.




























